Ildong Pharmaceutical Co., Ltd.
KRX:249420.KS
13070 (KRW) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -78,928.206 | -142,169.55 | -100,968.469 | -13,019.16 | -13,443.583 | 12,720.69 | 19,841.042 | 12,578.693 |
| Depreciation & Amortization
| 28,318.676 | 29,544.627 | 29,310.775 | 27,662.644 | 27,918.673 | 23,599.822 | 18,446.442 | 7,498.853 |
| Deferred Income Tax
| -39,050.526 | 0 | 51,399.88 | 23,400.7 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| -5.725 | 18.086 | 16.547 | 30.924 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -11,485.159 | -14,415.6 | -1,540.241 | -22,909.77 | -6,896.04 | 11,832.236 | 26,333.38 | -5,801.796 |
| Accounts Receivables
| -506.18 | -1,953.727 | -3,415.995 | 16,088.203 | 8,933.511 | 24,696.297 | 34,311.302 | 1,364.16 |
| Inventory
| 13,852.288 | -15,532.179 | 6,617.168 | -19,036.387 | -28,537.249 | 7,220.903 | 1,484.483 | 3,777.838 |
| Accounts Payables
| 4,234.993 | 7,935.651 | 2,338.894 | -3,723.733 | 19,222.584 | -6,186.717 | -4,094.459 | -5,932.813 |
| Other Working Capital
| -29,066.26 | -4,865.345 | -7,080.308 | -16,237.853 | -6,514.886 | 4,611.333 | 24,848.897 | -9,579.634 |
| Other Non Cash Items
| 64,535.543 | 73,481.78 | 10,415.55 | 4,200.263 | 33,786.6 | 18,494.087 | 9,103.322 | 4,881.131 |
| Operating Cash Flow
| -36,615.397 | -53,540.654 | -11,365.958 | 19,365.602 | 41,365.65 | 66,646.835 | 73,724.187 | 19,156.88 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -18,188.383 | -19,605.37 | -19,790.141 | -19,205.379 | -19,353.475 | -20,790.471 | -44,848.478 | -14,223.432 |
| Acquisitions Net
| 286.609 | 367.5 | 1,141.853 | 60 | -5,224.34 | 5,702.487 | -20,212.116 | -5,778.63 |
| Purchases Of Investments
| -46,000.839 | -74,734.921 | -28,218.009 | -2,239.755 | -8,238.353 | -2,707.443 | -12,220.805 | -504.703 |
| Sales Maturities Of Investments
| 44,400 | 67,333.782 | 5,038 | -60 | 10,565.813 | 959.721 | 1,231.891 | 569.195 |
| Other Investing Activites
| -927.837 | 203.562 | -1,539.589 | 3,041.836 | 8,223.967 | -5,761.662 | 28,164.926 | 6,155.888 |
| Investing Cash Flow
| -20,430.451 | -26,435.446 | -43,367.886 | -18,403.298 | -14,026.388 | -22,597.368 | -47,884.583 | -13,781.682 |
| Financing Activities: | ||||||||
| Debt Repayment
| -64,050 | -40,000 | -141,600 | -240,600 | -183,600 | -159,619.527 | -31,300 | -109,100 |
| Common Stock Issued
| 124.83 | 0 | 1,745.328 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -1,942.024 | 0 | 0 | -43.338 | -72.904 | -62.784 | -62.707 | -123.317 |
| Dividends Paid
| -160 | -120 | 0 | 0 | -8,632.314 | -7,848.485 | -5,352.119 | 0 |
| Other Financing Activities
| 124,249.548 | 36,832.821 | 244,170.492 | 236,067.705 | 178,821.547 | 159,619.527 | 31,300 | 109,100 |
| Financing Cash Flow
| 58,222.354 | -3,287.179 | 104,315.82 | -4,575.632 | -13,483.671 | -7,911.269 | -5,414.826 | -123.317 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -64.188 | -177.2 | 440.435 | -782.088 | 166.279 | -144.516 | -385.834 | 207.977 |
| Net Change In Cash
| 1,112.319 | -83,440.479 | 50,022.411 | -4,395.417 | 14,021.871 | 35,993.683 | 20,038.944 | 5,459.858 |
| Cash At End Of Period
| 53,258.173 | 52,145.854 | 135,586.333 | 85,563.922 | 89,959.339 | 75,937.468 | 39,943.786 | 19,904.841 |